Company Filing History:
Years Active: 2021-2023
Title: Hong-Yang Chuang: Innovator in Antibody-Drug Conjugates
Introduction
Hong-Yang Chuang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody-drug conjugates. With a total of 2 patents, his work is recognized for its innovative approach to drug delivery systems.
Latest Patents
Chuang's latest patents focus on antibody-drug conjugates (ADCs). One of his notable inventions describes an ADC with a specific structure represented by Formula (I). This structure includes a pharmaceutically acceptable salt, where Ab is an antibody without glycans, and various moieties that may differ. Another patent also details an ADC structure, emphasizing the unique combination of drug units and linker moieties that enhance therapeutic efficacy.
Career Highlights
Chuang is currently associated with Cho Pharma Inc., where he continues to advance research in the pharmaceutical sector. His work has been pivotal in developing new therapeutic strategies that leverage the specificity of antibodies to target cancer cells effectively.
Collaborations
Chuang has collaborated with notable colleagues, including Nan-Horng Lin and Charng-Sheng Tsai. These partnerships have fostered a collaborative environment that enhances innovation and research output.
Conclusion
Hong-Yang Chuang's contributions to the field of antibody-drug conjugates exemplify the importance of innovation in pharmaceuticals. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patient care.